公开(公告)号：NL2022494B1

公开(公告)日：2020-08-19

申请号：NL2022494

申请日：2019-02-01

Applicant: LAVA THERAPEUTICS B V ,  STICHTING VUMC

Inventor： JOHANNES JELLE VAN DER VLIET ,  IRIS DE WEERDT ,  TANJA DENISE DE GRUIJL ,  PAUL PARREN ,  ARNON PHILIP KATER ,  GEORGE LODEWIJK SCHEFFER

IPC: A61P35/00 ,  C07K16/28

Abstract: The present invention relates to novel antibodies capable of binding human CD40 and to novel multispecific antibodies capable of binding human CD40 and capable of binding a human Vy9V82 T cell receptor. The invention further relates to 5 pharmaceutical compositions comprising the antibodies of the invention and to uses of the antibodies of the invention for medical treatment.